
        <!DOCTYPE html>
    <html lang="ja">
    <style>
    body
    {
        color: black;
        background-color: white;
    }
    div{
        font-size: 14px;
    }
    span
    {
        font-size: 18px;
    }
    #grad1{
        background: linear-gradient(transparent 60%,#99e4f1 30%);
        font-size: 18px;
        font-weight: bold;
    }
    #grad2{
        background: linear-gradient(transparent 60%,#fda1a1 30%);
        font-size: 18px;
        font-weight: bold;
    }

    </style>

    <head>
        <meta charset="UTF-8">
        <title>101-107</title>
    </head>

    <body>
        <h1>
        <a href="./101_106.html" rel="external" title="prev">≪</a>
        101-107
        <a href="./101_108.html" rel="external" title="next">≫</a>
        </h1>
        <div class='problem'>
            <p>
                <span id="grad1">　問題文　</span>
            </p>
            <p>
                <p>ヒスタミンH<sub>1</sub>受容体拮抗薬であるレボセチリジン塩酸塩に関する記述のうち、正しいのはどれか。2つ選べ。</p>
<p><img alt="" class="alignnone size-full wp-image-3603" height="132.29999999999998" loading="lazy" sizes="(max-width: 353px) 100vw, 353px" src="data:;base64,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" width="247.1"/></p>
<ol><li>薬物名中のレボは左旋性に由来する。</li><li>血液脳関門を通過しやすくするため、カルボキシ基が導入されている。</li><li>エーテル結合の酸素原子は、水素結合のドナー(供与体)として、ヒスタミンH<sub>1</sub>受容体との結合親和性を高める。</li><li>セチリジンのラセミックスイッチ(キラルスイッチ)により開発された光学活性体である。</li></ol>    
            </p>
        </div>
        <hr>

        <input type="button" value="check ans" onclick="toggle_switch()"/>
        
        <div id='toggle'>
        <div class='answer'>
            <p>
                <span id="grad2">　解答　　</span>
            </p>
            <p>
            1, 4
            </p>
        </div>
        <div class='description'>
            <p>
                <span id="grad2">　解説　　</span>
            </p>
            <p>選択肢 1 は、正しい記述です。<br/>レボ＝levo で、左　を意味する言葉です。ちなみに、（－）で表されます。R や S と、旋性 は、関連がないことに注意が必要です。参考）</p>
<p>選択肢 2 ですが<br/>COOH 、つまりカルボキシル基は構造中に見られます。しかし、レボセチリジンは副作用である眠気等の軽減のために活性体である光学異性体のみを分離するという開発目的をもった薬です。眠気等は中枢性の副作用であることから、血液脳関門を通過しやすくなるという意図でカルボキシル基が導入された、という記述は不適当であると思います。</p>
<p>さらにそもそもカルボキシル基の導入は水溶性の増加　を意味します。そして、BBB を通過しやすいのは疎水性の物質です。従って、BBB を通過しやすくするために水溶性が増加するような、カルボキシル基を導入している、というのは誤りと考えられます。以上より、選択肢 2 は誤りです。</p>
<p>選択肢 3 ですが<br/>水素結合のドナー　とは、プロトンの供与体のことです。O－H　の H などです。酸素などの、陰性原子は「アクセプター」です。ドナーでは、ありません。参考）。よって、選択肢 3 は誤りです。</p>
<p>選択肢 4 は、正しい選択肢です。</p>
<p>以上より、正解は 1,4 です。</p>
            </p>
        </div>
        </div>
    </body>
    <script>
    document.getElementById("toggle").style.display="none";
    function toggle_switch(){
        var x = document.getElementById("toggle");
        if (x.style.display=="block"){
            x.style.display="none";
        }
        else{
            x.style.display="block";
        }
    }
    </script>
    